This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Resumen de acción CANTA BTA
A biotechnology company, develops antibody-based treatments for life threatening diseases.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Recompensas
Análisis de riesgos
Competidores de Cantargia AB (publ)
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | kr5.01 |
| 52 Week High | kr5.08 |
| 52 Week Low | kr4.85 |
| Beta | 1.48 |
| 1 Month Change | n/a |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 1.11% |
Noticias y actualizaciones recientes
Recent updates
Rentabilidad de los accionistas
| CANTA BTA | SE Biotechs | Mercado SE | |
|---|---|---|---|
| 7D | n/a | -2.6% | -2.1% |
| 1Y | n/a | 3.0% | 11.2% |
Rentabilidad vs. Industria: Insufficient data to determine how CANTA BTA performed against the Swedish Biotechs industry.
Rentabilidad vs. Mercado: Insufficient data to determine how CANTA BTA performed against the Swedish Market.
Volatilidad de los precios
| CANTA BTA volatility | |
|---|---|
| CANTA BTA Average Weekly Movement | n/a |
| Biotechs Industry Average Movement | 8.7% |
| Market Average Movement | 5.9% |
| 10% most volatile stocks in SE Market | 12.7% |
| 10% least volatile stocks in SE Market | 3.5% |
Precio estable de las acciones: CANTA BTA has not had significant price volatility in the past 3 months.
Volatilidad a lo largo del tiempo: Insufficient data to determine CANTA BTA's volatility change over the past year.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 2009 | 28 | Goran Forsberg | cantargia.com |
Resumen de fundamentos de Cantargia AB (publ)
| Estadísticas fundamentales de CANTA BTA | |
|---|---|
| Capitalización bursátil | kr512.49m |
| Beneficios(TTM) | -kr411.37m |
| Ingresos (TTM) | n/a |
0.0x
Ratio precio-ventas (PS)-1.2x
Ratio precio-beneficio (PE)¿Está CANTA BTA sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de CANTA BTA | |
|---|---|
| Ingresos | kr0 |
| Coste de los ingresos | kr0 |
| Beneficio bruto | kr0 |
| Otros gastos | kr411.37m |
| Beneficios | -kr411.37m |
Últimos beneficios comunicados
Mar 31, 2022
Próxima fecha de beneficios
Aug 30, 2022
| Beneficios por acción (BPA) | -4.11 |
| Margen bruto | 0.00% |
| Margen de beneficio neto | 0.00% |
| Ratio deuda/patrimonio | 0.0% |
¿Cómo se ha desempeñado CANTA BTA a largo plazo?
Ver rendimiento histórico y comparativa